Karin Eastham Nektar Therapeutics (NKTR) insider trading activity

NKTR Quotes by TradingView

Karin Eastham is Director of NEKTAR THERAPEUTICS. Currently has a direct ownership of 23,233 shares of NKTR, which is worth approximately $23,233. The most recent transaction as insider was on Sep 16, 2022, when has been sold 10,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.2K
0% 3M change
0% 12M change
Total Value Held $23,233

KARIN EASTHAM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2022
BUY
Grant, award, or other acquisition
-
10,200 Added 30.51%
23,233 Common Stock
Sep 13 2022
SELL
Open market or private sale
$76,774 $3.61 p/Share
21,267 Reduced 62.0%
13,033 Common Stock
Sep 22 2021
BUY
Grant, award, or other acquisition
-
10,200 Added 22.92%
34,300 Common Stock

Also insider at

VCYT
VERACYTE, INC. Healthcare
Director
GERN
GERON CORP Healthcare
Director
PSNL
Personalis, Inc. Healthcare
KE

Karin Eastham

Director
San Francisco, CA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTR